Cancer BiologybioRxiv
BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
R. Shrestha, N. Nabavi, Y.-Y. Lin…·C. C. Collins
The paper identifies BAP1 loss as a marker for a distinct immunogenic PeM subtype, suggesting potential therapeutic targets like immune checkpoint inhibitors.
DOI 10.1186/s13073-019-0620-3